Tri Suciati1, Safira Nafisa2, Tantri Liris Nareswari1, Meta Juniatik1, Elin Julianti1, Marlia Singgih Wibowo1, Titah Yudhistira3, Ihsanawati Ihsanawati4, Yani Triyani5, Khairurrijal Khairurrijal4,6. 1. School of Pharmacy, Bandung Institute of Technology, Bandung, Indonesia. 2. Faculty of Pharmacy, Pancasila University, Jakarta, Indonesia. 3. Faculty of Industrial Technology, Bandung Institute of Technology, Bandung, Indonesia. 4. Faculty of Mathematics and Natural Sciences, Bandung Institute of Technology, Bandung, Indonesia. 5. Faculty of Medicine, Bandung Islamic University, Bandung, Indonesia. 6. Bioscience and Biotechnology Research Center, Bandung Institute of Technology, Bandung, Indonesia.
Abstract
BACKGROUND AND AIM: An antimicrobial delivery in the form of surface-modified lectin of lipid nanoparticles was proposed to improve cellular accumulation. ArtinM, an active toll-like receptor 2 (TLR2) agonist lectin isolated from cempedak (Arthocarpus integrifolia) seeds, was selected to induce cellular engulfment of nanoparticles within infected host cells. MATERIALS AND METHODS: Lipid nanoparticles were prepared using the emulsification technique before electrostatic adsorption of artinM. The formula comprising of rifampicin, soy phospholipid, and polysorbate 80 was optimized by Box-Behnken design to produce the desired particle size, entrapment efficiency, and drug loading. The optimum formula was characterized for morphology, in vitro release, and cellular transport. RESULTS AND DISCUSSION: Soy phospholipid showed a profound effect on controlling drug loading and entrapment efficiency. Owing to its surface activity, polysorbate 80 contributed significantly to reduce particle size; however, a higher ratio to lipid concentration resulted in a decrease of rifampicin encapsulation. The adsorption of artinM on the surface of nanoparticles was accomplished by electrostatic binding at pH 4, where this process maintained the stability of encapsulated rifampicin. A high proportion of artinM adsorbed on the surface of the nanoparticles shown by haemagglutination assay, zeta potential measurement, and transmission electron microscopy imaging. Cellular uptake revealed by confocal microscopy showed the success in transporting Nile-red labelled nanoparticles across fibroblast cells. CONCLUSION: The delivery system of nanoparticles bearing artinM becomes a potential platform technology for antibiotic targeting in the treatment of life-threatening chronic diseases caused by intracellular infections.
BACKGROUND AND AIM: An antimicrobial delivery in the form of surface-modified lectin of lipid nanoparticles was proposed to improve cellular accumulation. ArtinM, an active toll-like receptor 2 (TLR2) agonist lectin isolated from cempedak (Arthocarpus integrifolia) seeds, was selected to induce cellular engulfment of nanoparticles within infected host cells. MATERIALS AND METHODS: Lipid nanoparticles were prepared using the emulsification technique before electrostatic adsorption of artinM. The formula comprising of rifampicin, soy phospholipid, and polysorbate 80 was optimized by Box-Behnken design to produce the desired particle size, entrapment efficiency, and drug loading. The optimum formula was characterized for morphology, in vitro release, and cellular transport. RESULTS AND DISCUSSION: Soy phospholipid showed a profound effect on controlling drug loading and entrapment efficiency. Owing to its surface activity, polysorbate 80 contributed significantly to reduce particle size; however, a higher ratio to lipid concentration resulted in a decrease of rifampicin encapsulation. The adsorption of artinM on the surface of nanoparticles was accomplished by electrostatic binding at pH 4, where this process maintained the stability of encapsulated rifampicin. A high proportion of artinM adsorbed on the surface of the nanoparticles shown by haemagglutination assay, zeta potential measurement, and transmission electron microscopy imaging. Cellular uptake revealed by confocal microscopy showed the success in transporting Nile-red labelled nanoparticles across fibroblast cells. CONCLUSION: The delivery system of nanoparticles bearing artinM becomes a potential platform technology for antibiotic targeting in the treatment of life-threatening chronic diseases caused by intracellular infections.
Authors: Mariana R D Cardoso; Caroline M Mota; Dâmaso P Ribeiro; Fernanda M Santiago; Julianne V Carvalho; Ester C B Araujo; Neide M Silva; Tiago W P Mineo; Maria C Roque-Barreira; José R Mineo; Deise A O Silva Journal: Vaccine Date: 2011-10-12 Impact factor: 3.641
Authors: Teresa Del Castillo-Santaella; José Manuel Peula-García; Julia Maldonado-Valderrama; Ana Belén Jódar-Reyes Journal: Colloids Surf B Biointerfaces Date: 2018-09-29 Impact factor: 5.268
Authors: Susan S Huang; Raveena Singh; James A McKinnell; Steven Park; Adrijana Gombosev; Samantha J Eells; Daniel L Gillen; Diane Kim; Syma Rashid; Raul Macias-Gil; Michael A Bolaris; Thomas Tjoa; Chenghua Cao; Suzie S Hong; Jennifer Lequieu; Eric Cui; Justin Chang; Jiayi He; Kaye Evans; Ellena Peterson; Gail Simpson; Philip Robinson; Chester Choi; Charles C Bailey; James D Leo; Alpesh Amin; Donald Goldmann; John A Jernigan; Richard Platt; Edward Septimus; Robert A Weinstein; Mary K Hayden; Loren G Miller Journal: N Engl J Med Date: 2019-02-14 Impact factor: 91.245
Authors: Steven Y C Tong; Joshua S Davis; Emily Eichenberger; Thomas L Holland; Vance G Fowler Journal: Clin Microbiol Rev Date: 2015-07 Impact factor: 26.132
Authors: Jana Musilova; Michelle E Mulcahy; Marieke M Kuijk; Rachel M McLoughlin; Andrew G Bowie Journal: J Biol Chem Date: 2019-09-26 Impact factor: 5.157